After announcing entry into the decorative paints business (through Grasim Industries), the Aditya Birla Group is now entering into the wires and cables business through UltraTech Cements. The initiative will further extend group’s footprint in the construction value chain. UltraTech will undertake the new business through it’s Building Products Division. The plant will be set … Read more
The initiative, part of the Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) scheme—launched in August 2023 for a five-year period—seeks to boost domestic R&D and reduce India’s reliance on imported technology. Also read: DCGI seeks post-market surveillance data on 2 combination drugs within 3 months “We are planning to float the expression … Read more
US President Donald Trump has announced a new visa program that will offer a “gold card” with a potential pathway to US citizenship for $5 million, that could significantly benefit Indian graduates and investors. This initiative, which Trump expects to generate significant revenue, is set to replace the existing EB-5 visa program. A new opportunity … Read more
The announcement by US President Donald Trump on Tuesday on the launch of a gold card investor visa programme, for wealthy immigrants, is likely to impact many Indians who are looking at applying for US green cards or permanent residency through the EB-5 visa route. President Trump told reporters on Tuesday that the new gold … Read more
This is further to the ongoing consolidation/ restructuring at Akzo Global. The Indian entity has been in the market to sell its decorative paints business. Now, it’s selling the power coatings business and the R&D centre to the Netherlands-based parent entity. Akzo Nobel N.V. (the parent) will be paying Rs 2,073 crore and Rs 70 … Read more
Indorama Ventures Public Company Limited, listed in Thailand, is one of the world’s leading chemicals producers, with manufacturing footprint across Europe, Africa, Americas, and Asia Pacific. Indorama is acquiring 24.9% of EPL from Blackstone at a purchase price of Rs 240 per share Blackstone currently holds 51.45% of the Company and is classified as the … Read more
Medicamen has recently won a new long term contract manufacturing contract from a US distributor. Company has now announced a board meeting on February 26, 2025 to consider a new fund raise. The intention is to raise some sort of equity (direct or convertible) by way of Preferential Issue/ Rights Issue/ QIP/ or any other … Read more
In a regulatory disclosure, Medicamen Biotech has informed that it has entered into a long-term Manufacturing & Supply Agreement with a prominent pharmaceutical distributor and marketing entity operating in the United States and Europe. Neither the name of the customer nor the financial details of the contract are disclosed. The company, however, has informed that collaboration … Read more